Mecobalamin IV Injection + Mecobalamin IM injection + Mecobalamin IV or IM injection
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Peripheral Neuropathy
Conditions
Peripheral Neuropathy
Trial Timeline
Apr 1, 2010 → May 1, 2011
NCT ID
NCT01192113About Mecobalamin IV Injection + Mecobalamin IM injection + Mecobalamin IV or IM injection
Mecobalamin IV Injection + Mecobalamin IM injection + Mecobalamin IV or IM injection is a approved stage product being developed by Eisai for Peripheral Neuropathy. The current trial status is completed. This product is registered under clinical trial identifier NCT01192113. Target conditions include Peripheral Neuropathy.
What happened to similar drugs?
8 of 20 similar drugs in Peripheral Neuropathy were approved
Approved (8) Terminated (3) Active (11)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01192113 | Approved | Completed |
Competing Products
20 competing products in Peripheral Neuropathy